BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32006785)

  • 1. Preclinical validation of [
    Emery S; Fieux S; Vidal B; Courault P; Bouvard S; Tourvieille C; Iecker T; Billard T; Zimmer L; Lancelot S
    Nucl Med Biol; 2020; 82-83():57-63. PubMed ID: 32006785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.
    Becker G; Colomb J; Sgambato-Faure V; Tremblay L; Billard T; Zimmer L
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):495-502. PubMed ID: 25331460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in Expression of 5-HT6 Receptor at Different Stages of Alzheimer's Disease: A Postmortem Study with the PET Radiopharmaceutical [18F]2FNQ1P.
    Courault P; Emery S; Bouvard S; Liger F; Chauveau F; Meyronet D; Fourier A; Billard T; Zimmer L; Lancelot S
    J Alzheimers Dis; 2020; 75(4):1329-1338. PubMed ID: 32417774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and Reliability of [
    Sgambato-Faure V; Billard T; Météreau E; Duperrier S; Fieux S; Costes N; Tremblay L; Zimmer L
    Front Pharmacol; 2017; 8():471. PubMed ID: 28769801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses, radiolabelings, and in vitro evaluations of fluorinated PET radioligands of 5-HT6 serotoninergic receptors.
    Colomb J; Becker G; Fieux S; Zimmer L; Billard T
    J Med Chem; 2014 May; 57(9):3884-90. PubMed ID: 24754711
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Vidal B; Fieux S; Colom M; Billard T; Bouillot C; Barret O; Constantinescu C; Tamagnan G; Newman-Tancredi A; Zimmer L
    Brain Struct Funct; 2018 Jul; 223(6):2973-2988. PubMed ID: 29730825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.
    Lemoine L; Andries J; Le Bars D; Billard T; Zimmer L
    J Nucl Med; 2011 Nov; 52(11):1811-8. PubMed ID: 21990574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers.
    Andries J; Lemoine L; Le Bars D; Zimmer L; Billard T
    Eur J Med Chem; 2011 Aug; 46(8):3455-61. PubMed ID: 21620533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptor.
    Parker CA; Gunn RN; Rabiner EA; Slifstein M; Comley R; Salinas C; Johnson CN; Jakobsen S; Houle S; Laruelle M; Cunningham VJ; Martarello L
    J Nucl Med; 2012 Feb; 53(2):295-303. PubMed ID: 22223878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation in rat and cat of [18F]12ST05 as a potential 5-HT6 PET radioligand.
    Tang S; Verdurand M; Joseph B; Lemoine L; Daoust A; Billard T; Fournet G; Le Bars D; Zimmer L
    Nucl Med Biol; 2007 Nov; 34(8):995-1002. PubMed ID: 17998104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
    Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
    J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Evaluation of
    Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
    J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
    Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of [
    Bongarzone S; Basagni F; Sementa T; Singh N; Gakpetor C; Faugeras V; Bordoloi J; Gee AD
    Nucl Med Biol; 2019; 68-69():14-21. PubMed ID: 30578137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
    Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
    J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
    Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
    Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
    Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
    Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite Study and Structural Authentication for the First-in-Human Use Sphingosine-1-phosphate Receptor 1 Radiotracer.
    Qiu L; Jiang H; Cho K; Yu Y; Jones LA; Huang T; Perlmutter JS; Gropler RJ; Brier MR; Patti GJ; Benzinger TLS; Tu Z
    ACS Chem Neurosci; 2024 May; 15(9):1882-1892. PubMed ID: 38634759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of structural alterations on the radiopharmacological profile of
    Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
    Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.